Literature DB >> 8862447

High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations.

C T Jordan1, G Yamasaki, D Minamoto.   

Abstract

We have developed a novel protocol for analysis of cell cycle status within specific subsets of primitive human hematopoietic cells. The technique, referred to as SID (surface, intracellular, and DNA) analysis, allows for the simultaneous characterization of cell surface and intracellular antigens, as well as quantitation of DNA content. To evaluate the technique, early human hematopoietic cells were examined using surface staining for the CD34 and CD38 antigens to identify primitive cells. Relative cell cycle status within defined phenotypic subsets (CD34+ and CD34+/CD38-) was determined by simultaneous two-parameter analysis using DNA content vs. antibody staining for the Ki-67 antigen. Ki-67 is not expressed in quiescent cells, but is quickly up-regulated as cells are induced to cycle. Consequently, expression of Ki-67, in combination with DNA content can be used to delineate all phases of the cell cycle (G0, G1, S, and GZ/M). We demonstrate that cycle induction of CD34+ cells, using IL-3, IL-6, and stem cell factor (SCF), does not correlate with activation of the CD34+CD38- subpopulation during ex vivo culture. Rather, CD34+/CD38- cells are much more refractory to cycle activation, requiring at least 72 hours to show significant levels of induction. In addition, primitive cells derived from bone marrow (BM) vs. mobilized peripheral blood (PB) show differing degrees of responsiveness to conventional ex vivo culture conditions. Finally, the effect of IL-3, IL-6, SCF, and Flt3 ligand (FL) on cycle induction was examined. It was observed that IL-3 synergized strongly with IL6+SCF to activate quiescent CD34+/CD38- cells. Moreover, when FL was combined with IL-3+IL-6+SCF, there was a small but reproducible increase in activation of CD34+/CD38- cells from G0 to G1. These data suggest that ex vivo behavior of primitive human stem cell populations is amenable to comprehensive flow cytometric analysis, and that such studies can provide detailed information on the biological response of stem cells to ex vivo culture and manipulation.

Entities:  

Mesh:

Year:  1996        PMID: 8862447

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  24 in total

1.  Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

Authors:  S S Case; M A Price; C T Jordan; X J Yu; L Wang; G Bauer; D L Haas; D Xu; R Stripecke; L Naldini; D B Kohn; G M Crooks
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor.

Authors:  P Kurre; H P Kiem; J Morris; S Heyward; J L Battini; A D Miller
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Hematopoietic stem/progenitor cells express functional mitochondrial energy-dependent cystic fibrosis transmembrane conductance regulator.

Authors:  Donatella Piro; Claudia Piccoli; Lorenzo Guerra; Francesca Sassone; Annamaria D'Aprile; Maria Favia; Stefano Castellani; Sante Di Gioia; Silvia Lepore; Maria Luisa Garavaglia; Teresa Trotta; Angela Bruna Maffione; Valeria Casavola; Giuliano Meyer; Nazzareno Capitanio; Massimo Conese
Journal:  Stem Cells Dev       Date:  2011-06-20       Impact factor: 3.272

4.  Anti-exudation effects of sodium ferulate and oxymatrine combination via modulation of aquaporin 1.

Authors:  Songmei Sun; Xing Du; Mengxin Xu; Meijuan Liu; Zhifeng Liu
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

5.  Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.

Authors:  Bin Zhang; Ling Li; Yinwei Ho; Min Li; Guido Marcucci; Wei Tong; Ravi Bhatia
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

6.  Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors.

Authors:  Mo A Dao; Joseph Hwa; Jan A Nolta
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

7.  Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.

Authors:  Garrett G Muramoto; J Lauren Russell; Rachid Safi; Alice B Salter; Heather A Himburg; Pamela Daher; Sarah K Meadows; Phuong Doan; Robert W Storms; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

8.  Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells.

Authors:  M A Dao; N Taylor; J A Nolta
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

9.  Pharmacological manipulation of the RAR/RXR signaling pathway maintains the repopulating capacity of hematopoietic stem cells in culture.

Authors:  Rachid Safi; Garrett G Muramoto; Alice B Salter; Sarah Meadows; Heather Himburg; Lauren Russell; Pamela Daher; Phuong Doan; Mark D Leibowitz; Nelson J Chao; Donald P McDonnell; John P Chute
Journal:  Mol Endocrinol       Date:  2008-12-23

10.  Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.

Authors:  Elizabeth M Algar; Andrea Muscat; Vinod Dagar; Christian Rickert; C W Chow; Jaclyn A Biegel; Paul G Ekert; Richard Saffery; Jeff Craig; Ricky W Johnstone; David M Ashley
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.